Díaz C - Search Results

1

3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.

Guijarro C, Blanco-Colio LM, Ortego M, Alonso C, Ortiz A, Plaza JJ, Díaz C, Hernández G, Egido J. Guijarro C, et al. Among authors: diaz c. Circ Res. 1998 Sep 7;83(5):490-500. doi: 10.1161/01.res.83.5.490. Circ Res. 1998. PMID: 9734471

2

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

Hernández-Presa MA, Martín-Ventura JL, Ortego M, Gómez-Hernández A, Tuñón J, Hernández-Vargas P, Blanco-Colio LM, Mas S, Aparicio C, Ortega L, Vivanco F, Gerique JG, Díaz C, Hernández G, Egido J. Hernández-Presa MA, et al. Among authors: diaz c. Atherosclerosis. 2002 Jan;160(1):49-58. doi: 10.1016/s0021-9150(01)00547-0. Atherosclerosis. 2002. PMID: 11755922

3

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.

Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J. Blanco-Colio LM, et al. Among authors: diaz c. Circulation. 2003 Sep 23;108(12):1506-13. doi: 10.1161/01.CIR.0000089086.48617.2B. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952848

4

HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells.

Ortego M, Gómez-Hernández A, Vidal C, Sánchez-Galán E, Blanco-Colio LM, Martín-Ventura JL, Tuñón J, Diaz C, Hernández G, Egido J. Ortego M, et al. Among authors: diaz c. J Cardiovasc Pharmacol. 2005 May;45(5):468-75. doi: 10.1097/01.fjc.0000159042.50488.e5. J Cardiovasc Pharmacol. 2005. PMID: 15821443

5

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis.

Bustos C, Hernández-Presa MA, Ortego M, Tuñón J, Ortega L, Pérez F, Díaz C, Hernández G, Egido J. Bustos C, et al. Among authors: diaz c. J Am Coll Cardiol. 1998 Dec;32(7):2057-64. doi: 10.1016/s0735-1097(98)00487-2. J Am Coll Cardiol. 1998. PMID: 9857893 Free article.

6

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells.

Ortego M, Bustos C, Hernández-Presa MA, Tuñón J, Díaz C, Hernández G, Egido J. Ortego M, et al. Among authors: diaz c. Atherosclerosis. 1999 Dec;147(2):253-61. doi: 10.1016/s0021-9150(99)00193-8. Atherosclerosis. 1999. PMID: 10559511

7

Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin.

Blanco-Colio LM, Martín-Ventura JL, Sol JM, Díaz C, Hernández G, Egido J. Blanco-Colio LM, et al. Among authors: diaz c. J Am Coll Cardiol. 2004 Apr 7;43(7):1188-94. doi: 10.1016/j.jacc.2003.10.046. J Am Coll Cardiol. 2004. PMID: 15063428 Free article. Clinical Trial.

8

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, Sánchez-Pascuala R, Hernández G, Díaz C, Lamas S. Hernández-Perera O, et al. Among authors: diaz c. J Clin Invest. 1998 Jun 15;101(12):2711-9. doi: 10.1172/JCI1500. J Clin Invest. 1998. PMID: 9637705 Free PMC article.

9

Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits.

Oubiña MP, de las Heras N, Cediel E, Sanz-Rosa D, Aragoncillo P, Díaz C, Hernández G, Lahera V, Cachofeiro V. Oubiña MP, et al. Among authors: diaz c. Clin Sci (Lond). 2003 Dec;105(6):655-62. doi: 10.1042/CS20030127. Clin Sci (Lond). 2003. PMID: 12848617

10

Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia.

Gómez-Gerique JA, Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, da Silva PM, Rodriguez-Botaro A, Zambón D, Lima J, Díaz C, Aristegui R, Sol JM, Chaves J, Hernández G; ATOMIX Investigators. Gómez-Gerique JA, et al. Among authors: diaz c. Atherosclerosis. 2002 Jun;162(2):245-51. doi: 10.1016/s0021-9150(01)00708-0. Atherosclerosis. 2002. PMID: 11996943 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,585 results

Search Page

Filters